Lucira Health, Inc. SEC Filings

Filed On	Filing
04 Oct 2023	15-12G
25 Sep 2023	8-K: Bankruptcy or Receivership; Material Modification to Rights of Security Holders +2 more
15 Aug 2023	NT 10-Q
29 Jun 2023	S-8 POS
29 Jun 2023	S-8 POS
12 Jun 2023	8-K: Other Events
16 May 2023	NT 10-Q
24 Apr 2023	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
18 Apr 2023	8-K: Entry into a Material Definitive Agreement
13 Apr 2023	NT 10-K
12 Apr 2023	25-NSE
10 Apr 2023	8-K: Other Events
05 Apr 2023	8-K: Other Events
13 Mar 2023	Form 4: Engelson Erik T., Director Received 574,666 shares by exercise or conversion ($471K) · Sold 634,666 shares ($657K)
13 Mar 2023	Form 4: Narido Richard Clavano, Chief Financial Officer Sold 25,091 shares ($27.3K) · Sold 1,910 shares ($1.09K) · Sold 2,382 shares ($1.07K)
13 Mar 2023	Form 4: Collins Kevin Walter, Chief Revenue Officer Sold 30,102 shares ($34.6K) · Sold 81,717 shares ($39.2K)
13 Mar 2023	Form 4: Allen Anthony Joseph, Chief Operations Officer Sold 8,405 shares ($8.41K)
27 Feb 2023	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure
22 Feb 2023	8-K: Bankruptcy or Receivership; Departure/Election of Directors or Officers; Compensation +1 more
21 Feb 2023	Form 4: Kashmolah Ghazi, Ex VP & Chief Quality Officer Sold 5,028 shares ($1.36K)

Comments